Observational study of myotonic dystrophy type 1
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study follows people with myotonic dystrophy type 1 over time to learn more about the condition. It is for people of any age who have genetic confirmation of DM1, whether or not they have symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a genetic test result that confirms you have myotonic dystrophy type 1 (DM1).
- You can have symptoms or not — either is fine.
- You cannot have another muscle disease, like limb-girdle muscular dystrophy.
- You should not have a serious health problem like heart, liver, or kidney disease or a major mental illness.
- You must be willing to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a long-term follow-up for people with myotonic dystrophy type 1. It aims to find better ways to measure how the disease progresses, which could help develop future treatments.
This study tests whether remote assessments can track myotonic dystrophy type 1 (DM1) and looks at genetic factors. It aims to find better ways to monitor the disease from home.
This study follows people with myotonic dystrophy type 1 (DM1) over time to learn more about how the disease progresses. It collects health information and samples to help improve care.
This study measures physical and lab “health markers” in people with myotonic dystrophy type 1 (DM1) to better understand how the disease changes over time. Some participants may also have a muscle biopsy to study tissue differences.
This study is following people with myotonic dystrophy over 24 months to better understand the disease by combining past medical records already in a registry with new check-ups. It doesn't test a new treatment but helps researchers learn about the condition, which may lead to better care in the future.
This study collects blood and, for some people, muscle tissue to look for signs (biomarkers) that can help track and better understand myotonic dystrophy. You may help by providing samples and basic muscle function testing, depending on your age and condition type.
Hear when a new Myotonic Dystrophy Type 1 (DM1) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.